NCT05819606 2025-09-22
PER2PSMA
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Completed
Clinical Trials
12 trialsNCT06778538 2025-01-16
HPGD-ccRCC
Lanzhou University Second Hospital
Completed
NCT06657755 2024-10-24
ENPP1-BC
Lanzhou University Second Hospital
Completed
NCT01026337 2019-06-25
Magnetic Resonance Imaging (MRI) in Predicting Response to Sunitinib Malate in Patients With Locally Advanced or Metastatic Kidney Cancer
Abramson Cancer Center at Penn Medicine
Completed
NCT00806650 2017-12-08
Anti-IMP3 Autoantibody and MicroRNA Signature Blood Tests in Finding Metastasis in Patients With Localized or Metastatic Kidney Cancer
City of Hope Medical Center
Completed
NCT00897351 2017-05-17
Study of Tissue and Blood Samples From Patients With Recurrent Prostate Cancer Who Received Lapatinib on Clinical Trial ECOG-E5803
Eastern Cooperative Oncology Group
Completed
NCT01553175 2016-07-14
Studying Gene Expression in Samples From Patients With Rhabdoid Tumors
Children's Oncology Group
Completed
NCT01542333 2016-05-18
Studying Biomarkers in Samples From Younger Patients With Wilms Tumor
Children's Oncology Group
Completed
NCT00900302 2016-02-10
OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer
OHSU Knight Cancer Institute
Completed
NCT00908739 2015-09-30
Studying Tumor Tissue Samples From Patients Who Have Undergone Surgery for Localized Kidney Cancer
Case Comprehensive Cancer Center
Withdrawn
NCT00899665 2014-02-11
Proteases in Patients With Prostate Cancer That Has Spread to the Bone
Barbara Ann Karmanos Cancer Institute
Completed
NCT00900536 2013-08-12
DNA Analysis of Blood and/or Tissue Samples From Patients With Primary Kidney Cancer Receiving Sorafenib on Clinical Trial MRC-RE05-SORCE
National Cancer Institute (NCI)
Completed